Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium.
Tianxin LinKaiwen LiHao LiuXueyi XueNing XuYong WeiZhiwen ChenXiaozhou ZhouLin QiWei HeShiyu TongFengshuo JinXudong LiuQiang WeiPing HanXin GouWeiyang HeXu ZhangGuoqiang YangZhoujun ShenTianyuan XuXin XieWei XueMing CaoJin YangJianyun HuFubao ChenPeijun LiGuangyong LiTong XuYe TianWenying WangDongkui SongLei ShiXiaoming YangYang YangBenkang ShiYaofeng ZhuXigao LiuJinchun XingZhun WuKaiyan ZhangWei LiChaozhao LiangCheng YangWei LiJinchun QiChuanliang XuWeidong XuLiqun ZhouLin CaiEn'ci XuWeizhong CaiMinggao WengYiming SuFangjian ZhouLijuan JiangZhuowei LiuQiuhong ChenTiejun PanBo LiuYu ZhouXin GaoJianguang QiuJie SituCheng HuShan ChenYupeng ZhengJian HuangPublished in: World journal of urology (2017)
ERAS did not increase 30-day complications compared with CRAS after RC. ERAS may be better than CRAS in terms of bowel movement, tolerance of fluid and regular diet, and ambulation.